...
首页> 外文期刊>Journal of Medicinal Chemistry >Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer
【24h】

Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer

机译:有效的游离脂肪酸受体1(FFA1)荧光示踪剂的开发和表征。

获取原文
获取原文并翻译 | 示例

摘要

The free fatty acid receptor 1 (FFA1/GPR40) is a potential target for treatment of type 2 diabetes. Although several potent agonists have been described, there remains a strong need for suitable tracers to interrogate ligand binding to this receptor. We address this by exploring fluorophoretethering to known potent FFA1 agonists. This led to the development of 4, a high affinity FFA1 tracer with favorable and polarity-dependent fluorescent properties. A close to ideal, overlap between the emission spectrum of the NanoLuciferase receptor tag and the excitation spectrum of 4 enabled the establishment of a homogeneous BRET-based binding assay suitable for both detailed kinetic studies and high throughput competition binding studies. Using 4 as a tracer demonstrated that the compound acts fully competitively with selected synthetic agonists but not with lauric acid and allowed for the characterization of binding affinities of a diverse selection of known FFA1 agonists, indicating that 4 will be a valuable tool for future studies at FFA1.
机译:游离脂肪酸受体1(FFA1 / GPR40)是治疗2型糖尿病的潜在靶标。尽管已经描述了几种有效的激动剂,但是仍然强烈需要合适的示踪剂来询问配体与该受体的结合。我们通过探索与已知的有效FFA1激动剂的荧光团醚化来解决此问题。这导致了高亲和力FFA1示踪剂4的开发,该示踪剂具有良好的极性依赖性荧光特性。纳米荧光素酶受体标签的发射光谱与4的激发光谱之间接近理想的重叠,使得能够建立适用于详细动力学研究和高通量竞争结合研究的均一的基于BRET的结合测定。使用4作为示踪剂证明该化合物与选定的合成激动剂具有完全竞争性作用,但与月桂酸不具有竞争性,并且可以表征多种已知FFA1激动剂的结合亲和力,这表明4将是在将来进行进一步研究的有价值的工具FFA1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号